Showing results (101-110 of 174) with videos related to
Sort By:
Pageof 18
Cancer Research and Treatment|August 6, 2021
The Clinical Outcomes of Different First-Line EGFR-TKIs Plus Bevacizumab in Advanced EGFR-Mutant Lung AdenocarcinomaYen-Hsiang Huang, Kuo-Hsuan Hsu, Chun-Shih Chin, et al.Cancer|September 22, 2006
Survival outcome and predictors of gefitinib antitumor activity in East Asian chemonaive patients with advanced nonsmall cell lung cancerChih-Hsin Yang, Jin-Yuan Shih, Kun-Chieh Chen, et al.Antibiotics (Basel, Switzerland)|September 28, 2024
In Vivo Effect of Halicin on Methicillin-Resistant <i>Staphylococcus aureus</i>-Infected <i>Caenorhabditis elegans</i> and Its Clinical PotentialLi-Ting Kao, Tsung-Ying Yang, Wei-Chun Hung, et al.Microorganisms|December 16, 2020
In Vitro and In Vivo Evaluations of β-Lactam/β-Lactamase Mono- and Combined Therapies against Carbapenem-Nonsusceptible Enterobacteriaceae in TaiwanTsung-Ying Yang, Ya-Ju Hsieh, Li-Ting Kao, et al.JAMA Network Open|March 30, 2022
Association of Smoking With Patient Characteristics and Outcomes in Small Cell Lung Carcinoma, 2011-2018Jeng-Sen Tseng, Chun-Ju Chiang, Kun-Chieh Chen, et al.Oncotargets and Therapy|April 1, 2021
Primary Tumor Radiotherapy During EGFR-TKI Disease Control Improves Survival of Treatment Naïve Advanced EGFR-Mutant Lung Adenocarcinoma PatientsKuo-Hsuan Hsu, Jing-Wen Huang, Jeng-Sen Tseng, et al.Cancer Research and Treatment|January 16, 2018
The Association of Acquired T790M Mutation with Clinical Characteristics after Resistance to First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung AdenocarcinomaYen-Hsiang Huang, Kuo-Hsuan Hsu, Jeng-Sen Tseng, et al.Lung Cancer (Amsterdam, Netherlands)|January 16, 2019
High PD-L1 expression correlates with primary resistance to EGFR-TKIs in treatment naïve advanced EGFR-mutant lung adenocarcinoma patientsKuo-Hsuan Hsu, Yen-Hsiang Huang, Jeng-Sen Tseng, et al.Cancers|July 27, 2022
Overall Survival Improvement in Patients with Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer and Bone Metastasis Treated with DenosumabHow-Wen Ko, Chi-Tsun Chiu, Chih-Liang Wang, et al.Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|July 15, 2017
The plasmid-mediated fosfomycin resistance determinants and synergy of fosfomycin and meropenem in carbapenem-resistant Klebsiella pneumoniae isolates in TaiwanSung-Pin Tseng, Sheng-Fan Wang, Ling Ma, et al.Pageof 18